![](/img/cover-not-exists.png)
A phase 1, randomized, double-blind, placebo-controlled dose-escalating, safety, tolerability, pharmacokinetic, and pharmacodynamic study of oral recombinant human interleukin eleven (O-rhIl-11) in normal healthy subjects
Cotreau, Monette M., Stonis, Lucille, Schwertschlag, Ullrich S.Volume:
124
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(03)81907-8
Date:
April, 2003
File:
PDF, 170 KB
english, 2003